Rachel Fong
About Rachel Fong
Rachel Fong is the Director of Sales and Alliances at Integral Molecular, where she has worked since 2010 in various roles, including Senior Project Leader and Alliance Manager. She holds a B.S. in Biology from Drexel University and has contributed to over a dozen publications in her field.
Current Role at Integral Molecular
Rachel Fong serves as the Director of Sales and Alliances at Integral Molecular, a position she has held since 2022. In this role, she is responsible for leading sales strategies and establishing partnerships to enhance the company's market presence. Her experience in alliance management and project leadership contributes to her effectiveness in this position.
Previous Positions at Integral Molecular
Rachel Fong has held multiple roles at Integral Molecular since joining the company in 2010. She worked as a Research Associate I for five months, followed by a year as a Research Associate II. She then progressed to Senior Research Associate I from 2012 to 2014, and later served as Project Leader for Epitope Mapping from 2014 to 2020. Additionally, she worked as Alliance Manager for five months in 2020 before transitioning to her current role.
Education and Academic Background
Rachel Fong earned a Bachelor of Science degree in Biology from Drexel University, where she studied from 2005 to 2010. Her academic background has provided her with a solid foundation in biological sciences, which has been instrumental in her career in the biotechnology sector.
Experience at Sanofi-Aventis
Prior to her extensive career at Integral Molecular, Rachel Fong gained experience at Sanofi-Aventis. She worked as a Research Technician Intern in two separate roles, first from 2007 to 2008 and then from 2008 to 2009. During her time there, she contributed to projects in the GMPK group, enhancing her practical knowledge in research and development.
Publications and Contributions
Rachel Fong has authored over a dozen publications throughout her career. She has played a significant role in scientific advancements, including being a founding member of the teams that launched the Shotgun Mutagenesis Epitope Mapping and Membrane Proteome Array platforms. Her contributions have had a notable impact on the field of biotechnology.